Lyophilized Injectable Drugs Market Analysis

Lyophilized Injectable Drugs Market Analysis

On the basis of drug type, the anti-infective lyophilized injectable drugs market size is anticipated to reach over USD 311 billion by 2032 attributed to the surging incidences of various infectious diseases, such as HIV, herpes simplex virus, influenza, and hepatitis virus. It has been estimated that nearly 1 in 6 people aged between 14 to 50 years are affected by hepatitis virus infection and about 1.2 million people are presently suffering from HIV in the U.S.
 

Based on indication, the lyophilized injectable drugs market share from the oncology segment may surpass USD 290 billion by 2032 due to the increasing cancer treatment awareness worldwide. The surge in technological developments has led to the growing number of R&D activities related to cancer. There has also been a significant rise in the instances of launches of new cancer medications by prominent biopharmaceutical companies. The escalating concerns pertaining to the rising cancer death rates will also play a key role in the segment progression.
 

With respect to packaging, the lyophilized injectable drugs market share from the cartridges segment is poised to depict 13.7% CAGR by 2032 driven by benefits, such as ease of use and enhanced accessibility. Single chamber and dual-chamber cartridges have grown widely popular as they are suitable for simple drug delivery and pen systems.  The access to low residual moisture and careful calibration with pen systems are other factors driving the demand for cartridge-packaged lyophilized injectable drugs.
 

North America recorded over 47% share of the lyophilized injectable drugs market in 2022. The rising prevalence of chronic diseases has led to the surging need for well-established healthcare infrastructure in the region. According to the CDC (Centers for Disease Control and Prevention), 6 in 10 adults across the U.S. suffer from a chronic disease. The robust presence of favorable reimbursement scenario will contribute to the regional market expansion.